Prevacid
NDC Package 70518-0502-0

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Prevacid is lansoprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). Marketed by Remedyrepack Inc., this product is identified by NDC 70518-0502 and is authorized under FDA application NDA020406.

Identification & Billing

NDC Package Code
70518-0502-0
Package Description
10 CAPSULE, DELAYED RELEASE in 1 BOTTLE, PLASTIC
Product Code
70518-0502
11-Digit Billing Format
70518050200

Clinical Specifications

Proprietary Name
Prevacid
Dosage Form
-
Usage Information
Lansoprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as heartburn, difficulty swallowing, and persistent cough. This medication helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Lansoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs).

Regulatory & Marketing

Labeler Name
Remedyrepack Inc.
FDA Application #
NDA020406
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
05-09-2017
End Marketing Date
04-06-2020
Listing Expiration
04-06-2020
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70518-0502-0 identifies a specific commercial package of 10 capsule, delayed release in 1 bottle, plastic of Prevacid, labeled by Remedyrepack Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Remedyrepack Inc. on May 09, 2017. The current certification is valid through April 06, 2020.

What are the primary indications for this medication?

Lansoprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as heartburn, difficulty swallowing, and persistent cough. This medication helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Lansoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs).

How is this Remedyrepack Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70518050200. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
70518-0502-0
11-Digit CMS (5-4-2)
70518-0502-00

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.